Squarepoint Ops LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,313,810
-19.4%
159,012
-27.2%
0.01%
-52.9%
Q1 2023$4,112,735
-47.2%
218,530
-54.1%
0.02%
-56.4%
Q3 2022$7,786,000
+11.7%
475,921
-3.8%
0.04%0.0%
Q2 2022$6,970,000
+44.2%
494,702
+147.8%
0.04%
+85.7%
Q1 2022$4,835,000
+579.1%
199,623
+554.7%
0.02%
+950.0%
Q4 2021$712,000
-62.9%
30,491
-73.6%
0.00%
-66.7%
Q3 2021$1,919,000
+10.0%
115,550
+254.3%
0.01%
-53.8%
Q4 2020$1,744,000
-79.8%
32,616
-84.4%
0.01%
-88.9%
Q3 2020$8,649,000
+169.8%
209,673
+217.0%
0.12%
+125.0%
Q2 2020$3,206,000
-4.4%
66,139
-16.6%
0.05%
-39.5%
Q1 2020$3,352,000
-66.2%
79,336
-65.8%
0.09%
+45.8%
Q4 2019$9,923,000
+258.2%
231,957
+201.4%
0.06%
+136.0%
Q3 2019$2,770,000
+522.5%
76,955
+179.4%
0.02%
+400.0%
Q4 2018$445,000
-57.5%
27,541
-45.3%
0.01%
-61.5%
Q3 2018$1,046,000
-31.5%
50,364
-25.9%
0.01%
-45.8%
Q1 2018$1,527,000
-32.9%
67,965
-10.1%
0.02%
-40.0%
Q4 2017$2,277,000
+81.7%
75,613
+127.4%
0.04%
+66.7%
Q3 2017$1,253,000
-44.4%
33,256
-49.3%
0.02%
-61.3%
Q1 2017$2,255,000
-5.6%
65,586
-10.9%
0.06%
-58.4%
Q2 2016$2,389,000
+551.0%
73,600
+614.6%
0.15%
+272.5%
Q4 2015$367,00010,3000.04%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders